149 related articles for article (PubMed ID: 36047147)
1. [Current status of MPS research toward social implementation].
Sakai Y; Kimura H
Nihon Yakurigaku Zasshi; 2022; 157(5):330-334. PubMed ID: 36047147
[TBL] [Abstract][Full Text] [Related]
2. [Development of Microphysiological Systems (MPSs) Based on Microfluidic Technology for Drug Discovery in Japan].
Kimura H
Yakugaku Zasshi; 2023; 143(1):39-44. PubMed ID: 36596538
[TBL] [Abstract][Full Text] [Related]
3. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
[TBL] [Abstract][Full Text] [Related]
4. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
Yamazaki D
Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
[TBL] [Abstract][Full Text] [Related]
5. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
[TBL] [Abstract][Full Text] [Related]
6. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
Watson DE; Hunziker R; Wikswo JP
Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
[TBL] [Abstract][Full Text] [Related]
7. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications.
Fabre K; Berridge B; Proctor WR; Ralston S; Will Y; Baran SW; Yoder G; Van Vleet TR
Lab Chip; 2020 Mar; 20(6):1049-1057. PubMed ID: 32073020
[TBL] [Abstract][Full Text] [Related]
8. Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project.
Ishida S
Front Toxicol; 2021; 3():657765. PubMed ID: 35295097
[TBL] [Abstract][Full Text] [Related]
9. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
[TBL] [Abstract][Full Text] [Related]
10. [Pharma challenges to adoption of microphysiological system in drug research and development, especially safety assessment].
Naraoka H
Nihon Yakurigaku Zasshi; 2023; 158(2):187-192. PubMed ID: 36858504
[TBL] [Abstract][Full Text] [Related]
11. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
[TBL] [Abstract][Full Text] [Related]
12. Technical aspects of microphysiological systems (MPS) as a promising wet human-in-vivo simulator.
Kanamori T; Sugiura S; Sakai Y
Drug Metab Pharmacokinet; 2018 Feb; 33(1):40-42. PubMed ID: 29217459
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Utilizing microphysiological systems and induced pluripotent stem cells for disease modeling: a case study for blood brain barrier research in a pharmaceutical setting.
Fabre KM; Delsing L; Hicks R; Colclough N; Crowther DC; Ewart L
Adv Drug Deliv Rev; 2019 Feb; 140():129-135. PubMed ID: 30253201
[TBL] [Abstract][Full Text] [Related]
15. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
[TBL] [Abstract][Full Text] [Related]
16. Imaging microphysiological systems: a review.
Peel S; Jackman M
Am J Physiol Cell Physiol; 2021 May; 320(5):C669-C680. PubMed ID: 33356942
[TBL] [Abstract][Full Text] [Related]
17. Microphysiological Systems: A Pathologist's Perspective.
Sura R; Van Vleet T; Berridge BR
Vet Pathol; 2020 May; 57(3):358-368. PubMed ID: 32180532
[TBL] [Abstract][Full Text] [Related]
18. Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development.
Tomlinson L; Ramsden D; Leite SB; Beken S; Bonzo JA; Brown P; Candarlioglu PL; Chan TS; Chen E; Choi CK; David R; Delrue N; Devine PJ; Ford K; Garcia MI; Gosset JR; Hewitt P; Homan K; Irrechukwu O; Kopec AK; Liras JL; Mandlekar S; Raczynski A; Sadrieh N; Sakatis MZ; Siegel J; Sung K; Sunyovszki I; Van Vleet TR; Ekert JE; Hardwick RN
Adv Biol (Weinh); 2023 Oct; ():e2300131. PubMed ID: 37814378
[TBL] [Abstract][Full Text] [Related]
19. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
Hughes DJ; Kostrzewski T; Sceats EL
Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
